The purpose of this study is to confirm that prognosis of Intrahepatic Cholangiocarcinoma (ICC) with resection and radiotherapy ,to find which is safe and effective treatment.
Intrahepatic Cholangiocarcinoma (ICC), the second most common primary liver cancer and constitutes 10% of primary liver malignancies. Current therapies for the treatment of ICC are ineffective and the role of liver transplantation is not well defined. This study reviews our experience with this tumor and looks for preoperative and pathologic indices that may help determine long term prognosis
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
200
Eastern Hepatobiliary Surgery Hospital
Shanghai, Shanghai Municipality, China
RECRUITINGthe overall survival rate of each group
Time frame: 3 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.